Efficacy of a long-acting anti-interleukin 1 agent is reported in an adult with a typical pediatric disease, PFAPA syndrome.
Lopalco, G., Rigante, D., Vitale, A., Caso, F., Iannone, F., Cantarini, L., Canakinumab efficacy in refractory adult-onset PFAPA syndrome, <<INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES>>, N/A; 2015 (N/A): N/A-N/A. [doi:10.1111/1756-185X.12722] [http://hdl.handle.net/10807/68747]
Canakinumab efficacy in refractory adult-onset PFAPA syndrome
Rigante, Donato;
2015
Abstract
Efficacy of a long-acting anti-interleukin 1 agent is reported in an adult with a typical pediatric disease, PFAPA syndrome.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
